On the public citation graph
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
0 signed · 868 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamaoncol.2019.0250openalex-snapshot
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
inferredcites →https://doi.org/10.1001/jamaoncol.2020.4564openalex-snapshot
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
inferredcites →https://doi.org/10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-eopenalex-snapshot
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
inferredcites →https://doi.org/10.1002/1097-0142(19870815)60:4<810::aid-cncr2820600417>3.0.co;2-1openalex-snapshot
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification
inferredcites →https://doi.org/10.1002/1097-0142(19880415)61:8<1621::aid-cncr2820610820>3.0.co;2-copenalex-snapshot
Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/ags3.12052openalex-snapshot
Surgical outcomes in gastroenterological surgery in Japan: Report of National Clinical database 2011–2016
inferredcites →https://doi.org/10.1002/ags3.12258openalex-snapshot
Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011‐2017
inferredcites →https://doi.org/10.1002/cam4.1909openalex-snapshot
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
inferredcites →https://doi.org/10.1002/cld.802openalex-snapshot
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/cncr.24196openalex-snapshot
Percutaneous thermal ablation of medium and large hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.1840120625openalex-snapshot
α-fetoprotein: Reevaluation in hepatology
inferredcites →https://doi.org/10.1002/hep.1840170110openalex-snapshot
Fucosylation Index of α-Fetoprotein, a Possible Aid in the Early Recognition of Hepatocellular Carcinoma in Patients with Cirrhosis
inferredcites →https://doi.org/10.1002/hep.1840220116openalex-snapshot
Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins
inferredcites →https://doi.org/10.1002/hep.20486openalex-snapshot
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
inferredcites →https://doi.org/10.1002/hep.22709openalex-snapshot
Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †
inferredcites →https://doi.org/10.1002/hep.27290openalex-snapshot
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
inferredcites →https://doi.org/10.1002/hep.29225openalex-snapshot
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey
inferredcites →https://doi.org/10.1002/hep.29913openalex-snapshot
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/hep.510280322openalex-snapshot
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
inferredcites →https://doi.org/10.1002/hep.510280511openalex-snapshot
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
inferredcites →https://doi.org/10.1002/jcu.22080openalex-snapshot
The gross classification of hepatocellular carcinoma: Usefulness of contrast‐enhanced US
inferredcites →https://doi.org/10.1002/jmri.22630openalex-snapshot
Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease
inferredcites →https://doi.org/10.1002/jmri.25079openalex-snapshot
Can combining triple‐arterial phase acquisition with fluoroscopic triggering provide both optimal early and late hepatic arterial phase images during gadoxetic acid‐enhanced MRI?
inferredcites →https://doi.org/10.1002/jmri.25345openalex-snapshot
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1007/s00270-009-9711-7openalex-snapshot
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
inferredcites →https://doi.org/10.1007/s00330-010-1812-9openalex-snapshot
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow
inferredcites →https://doi.org/10.1007/s00330-011-2165-8openalex-snapshot
The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging
inferredcites →https://doi.org/10.1007/s00534-009-0234-zopenalex-snapshot
Interventional oncology: new options for interstitial treatments and intravascular approaches
inferredcites →https://doi.org/10.1007/s00535-005-1751-4openalex-snapshot
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy
inferredcites →https://doi.org/10.1007/s00535-006-1878-yopenalex-snapshot
A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00535-008-2274-6openalex-snapshot
Multistep human hepatocarcinogenesis: correlation of imaging with pathology
inferredcites →https://doi.org/10.1007/s00535-009-0053-7openalex-snapshot
Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images
inferredcites →https://doi.org/10.1007/s00535-009-0056-4openalex-snapshot
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00535-013-0830-1openalex-snapshot
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography
inferredcites →https://doi.org/10.1007/s00535-013-0853-7openalex-snapshot
Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization
inferredcites →https://doi.org/10.1007/s00535-013-0859-1openalex-snapshot
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI
inferredcites →https://doi.org/10.1007/s00535-015-1094-8openalex-snapshot
Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study
inferredcites →https://doi.org/10.1007/s00535-017-1321-6openalex-snapshot
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey
inferredcites →https://doi.org/10.1007/s00535-019-01642-1openalex-snapshot
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
inferredcites →https://doi.org/10.1007/s00535-020-01753-0openalex-snapshot
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
inferredcites →https://doi.org/10.1007/s005350300038openalex-snapshot
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
inferredcites →https://doi.org/10.1007/s12072-016-9771-0openalex-snapshot
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
inferredcites →https://doi.org/10.1007/s12072-017-9799-9openalex-snapshot
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
inferredcites →https://doi.org/10.1016/0046-8177(91)90039-ropenalex-snapshot
Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.annonc.2020.04.059openalex-snapshot
O-6 The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.cgh.2006.09.021openalex-snapshot
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers
inferredcites →https://doi.org/10.1016/j.dld.2016.02.005openalex-snapshot
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
inferredcites →https://doi.org/10.1016/j.ejca.2011.05.007openalex-snapshot
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2012.06.014openalex-snapshot
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
inferredcites →https://doi.org/10.1016/j.jhep.2012.09.026openalex-snapshot
Marginal survival benefit in the treatment of early hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2014.01.006openalex-snapshot
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2016.01.012openalex-snapshot
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.044openalex-snapshot
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
inferredcites →https://doi.org/10.1016/j.jhep.2017.07.009openalex-snapshot
Molecular classification of hepatocellular adenoma in clinical practice
inferredcites →https://doi.org/10.1016/j.jhep.2018.03.019openalex-snapshot
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jvir.2006.12.004openalex-snapshot
Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil
inferredcites →https://doi.org/10.1016/j.jvir.2016.04.014openalex-snapshot
Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome
inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2009.05.013openalex-snapshot
Definition of Contrast Enhancement Phases of the Liver Using a Perfluoro-Based Microbubble Agent, Perflubutane Microbubbles
inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2012.09.002openalex-snapshot
Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012
inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2020.04.030openalex-snapshot
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
inferredcites →https://doi.org/10.1016/s0140-6736(02)08649-xopenalex-snapshot
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(16)32453-9openalex-snapshot
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
inferredcites →https://doi.org/10.1016/s0140-6736(17)31046-2openalex-snapshot
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
inferredcites →https://doi.org/10.1016/s0140-6736(18)30010-2openalex-snapshot
Hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0140-6736(18)30207-1openalex-snapshot
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
inferredcites →https://doi.org/10.1016/s0168-8278(00)80369-4openalex-snapshot
Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans
inferredcites →https://doi.org/10.1016/s0618-8278(19)31229-0openalex-snapshot
FRI-494-Practice patterns and outcomes of transarterial chemoembolization in patients with hepatocellular carcinoma who were ineligible and eligible for transarterial chemoembolization at inclusion: Global OPTIMIS exploratory analysis
inferredcites →https://doi.org/10.1016/s1001-9294(11)60041-2openalex-snapshot
Serum HIF-1α and VEGF Levels Pre- and Post-TACE in Patients with Primary Liver Cancer
inferredcites →https://doi.org/10.1016/s1386-6346(03)00007-xopenalex-snapshot
Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type
inferredcites →https://doi.org/10.1016/s1470-2045(08)70284-5openalex-snapshot
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
inferredcites →https://doi.org/10.1016/s1470-2045(08)70285-7openalex-snapshot
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(18)30351-6openalex-snapshot
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(18)30937-9openalex-snapshot
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
inferredcites →https://doi.org/10.1016/s2468-1253(17)30156-5openalex-snapshot
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
inferredcites →https://doi.org/10.1016/s2468-1253(17)30290-xopenalex-snapshot
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
inferredcites →https://doi.org/10.1016/s2468-1253(18)30078-5openalex-snapshot
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
inferredcites →https://doi.org/10.1038/35025220openalex-snapshot
Angiogenesis in cancer and other diseases
inferredcites →https://doi.org/10.1038/ajg.2010.432openalex-snapshot
Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1038/bjc.2013.542openalex-snapshot
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
inferredcites →https://doi.org/10.1038/bjc.2014.199openalex-snapshot
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1038/nm988openalex-snapshot
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
inferredcites →https://doi.org/10.1038/sj.bjc.6604282openalex-snapshot
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
inferredcites →https://doi.org/10.1053/j.gastro.2005.04.009openalex-snapshot
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2008.02.091openalex-snapshot
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2014.02.032openalex-snapshot
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2015.12.041openalex-snapshot
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1053/jhep.2000.9113openalex-snapshot
Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading
inferredcites →https://doi.org/10.1053/jhep.2001.24233openalex-snapshot
Increased Risk of Tumor Seeding After Percutaneous Radiofrequency Ablation for Single Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1055/s-0032-1329906openalex-snapshot
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
inferredcites →https://doi.org/10.1055/s-2007-1007122openalex-snapshot
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
inferredcites →https://doi.org/10.1056/nejm198405313102204openalex-snapshot
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1056/nejmoa0708857openalex-snapshot
Sorafenib in Advanced Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1056/nejmoa1717002openalex-snapshot
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1056/nejmoa1915745openalex-snapshot
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1073/pnas.93.25.14765openalex-snapshot
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
inferredcites →https://doi.org/10.1093/annonc/mdw323openalex-snapshot
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
inferredcites →https://doi.org/10.1097/01.sla.0000201480.65519.b8openalex-snapshot
A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/md.0000000000001772openalex-snapshot
Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/sla.0b013e3181efc656openalex-snapshot
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
inferredcites →https://doi.org/10.1111/hepr.12266openalex-snapshot
Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib
inferredcites →https://doi.org/10.1111/hepr.12464openalex-snapshot
Evidence‐based C linical P ractice G uidelines for H epatocellular C arcinoma: The J apan S ociety of H epatology 2013 update (3rd JSH‐HCC G uidelines)
inferredcites →https://doi.org/10.1111/hepr.12544openalex-snapshot
Highly sensitive alpha‐fetoprotein, Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein and des‐gamma‐carboxyprothrombin for hepatocellular carcinoma detection
inferredcites →https://doi.org/10.1111/hepr.13048openalex-snapshot
Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization
inferredcites →https://doi.org/10.1111/hepr.13364openalex-snapshot
Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society
inferredcites →https://doi.org/10.1111/hepr.13411openalex-snapshot
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
inferredcites →https://doi.org/10.1111/hepr.13438openalex-snapshot
Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan
inferredcites →https://doi.org/10.1111/j.1349-7006.2008.01003.xopenalex-snapshot
Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor‐β receptor inhibitor on extravasation of nanoparticles from neovasculature
inferredcites →https://doi.org/10.1111/j.1440-1746.1994.tb01569.xopenalex-snapshot
Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views
inferredcites →https://doi.org/10.1111/j.1440-1746.2005.03841.xopenalex-snapshot
IMPACT OF TUMOR FACTORS ON THE PROGNOSIS OF PATIENTS WITH ADVANCED CIRRHOSIS (CHILD–PUGH CLASS C) AND HEPATOCELLULAR CARCINOMA
inferredcites →https://doi.org/10.1111/j.1872-034x.2007.00216.xopenalex-snapshot
Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
inferredcites →https://doi.org/10.1111/j.1872-034x.2010.00650.xopenalex-snapshot
The committee for revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1111/j.1872-034x.2012.01025.xopenalex-snapshot
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients
inferredcites →https://doi.org/10.1111/jgh.12162openalex-snapshot
A systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm
inferredcites →https://doi.org/10.1111/jgh.13250openalex-snapshot
Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/jgh.13586openalex-snapshot
Application of radiofrequency ablation for the treatment of intermediate‐stage hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/jgh.14152openalex-snapshot
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
inferredcites →https://doi.org/10.1111/liv.12314openalex-snapshot
Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
inferredcites →https://doi.org/10.1111/liv.13096openalex-snapshot
Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study
inferredcites →https://doi.org/10.1126/science.1104819openalex-snapshot
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
inferredcites →https://doi.org/10.1136/gut.2003.035055openalex-snapshot
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
inferredcites →https://doi.org/10.1136/gutjnl-2019-318934openalex-snapshot
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
inferredcites →https://doi.org/10.1148/radiol.10091885openalex-snapshot
Distinguishing Hypervascular Pseudolesions of the Liver from Hypervascular Hepatocellular Carcinomas with Gadoxetic Acid–enhanced MR Imaging
inferredcites →https://doi.org/10.1148/radiol.10092214openalex-snapshot
Hepatocellular Carcinoma: Signal Intensity at Gadoxetic Acid–enhanced MR Imaging—Correlation with Molecular Transporters and Histopathologic Features
inferredcites →https://doi.org/10.1148/radiol.11101840openalex-snapshot
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
inferredcites →https://doi.org/10.1148/radiol.12112677openalex-snapshot
Hypovascular Nodules in Patients with Chronic Liver Disease: Risk Factors for Development of Hypervascular Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1148/radiol.14140690openalex-snapshot
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1148/radiol.14141315openalex-snapshot
Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics
inferredcites →https://doi.org/10.1148/radiology.148.2.6306721openalex-snapshot
Hepatic artery embolization in 120 patients with unresectable hepatoma.
inferredcites →https://doi.org/10.1148/radiology.154.1.2981114openalex-snapshot
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
inferredcites →https://doi.org/10.1148/radiology.178.2.1846240openalex-snapshot
Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.
inferredcites →https://doi.org/10.1148/radiology.182.1.1309217openalex-snapshot
Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging.
inferredcites →https://doi.org/10.1148/radiology.183.3.1316622openalex-snapshot
Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings.
inferredcites →https://doi.org/10.1148/radiology.196.3.7644646openalex-snapshot
US-guided liver biopsy: predicting the effect of interventional treatment of hepatocellular carcinoma.
inferredcites →https://doi.org/10.1148/radiology.218.3.r01mr39763openalex-snapshot
Hypervascular Hepatocellular Carcinoma: Detection with Double Arterial Phase Multi-Detector Row Helical CT
inferredcites →https://doi.org/10.11501/3086943openalex-snapshot
Early stages of multistep hepatocarcinogenesis : adenomatous hyperplasia and early hepatocellular carcinoma
inferredcites →https://doi.org/10.1155/2014/638747openalex-snapshot
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
inferredcites →https://doi.org/10.1159/000078475openalex-snapshot
Atypical Large Well-Differentiated Hepatocellular Carcinoma with Benign Nature: A New Clinical Entity
inferredcites →https://doi.org/10.1159/000111702openalex-snapshot
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology
inferredcites →https://doi.org/10.1159/000111710openalex-snapshot
Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 Patients
inferredcites →https://doi.org/10.1159/000122599openalex-snapshot
A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score
inferredcites →https://doi.org/10.1159/000122600openalex-snapshot
Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid
inferredcites →https://doi.org/10.1159/000315229openalex-snapshot
Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000327577openalex-snapshot
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
inferredcites →https://doi.org/10.1159/000342749openalex-snapshot
Japans Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance
inferredcites →https://doi.org/10.1159/000343867openalex-snapshot
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
inferredcites →https://doi.org/10.1159/000343875openalex-snapshot
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
inferredcites →https://doi.org/10.1159/000355259openalex-snapshot
Hepatocellular Carcinoma in Child-Pugh C Cirrhosis: Prognostic Factors and Survival Benefit of Nontransplant Treatments
inferredcites →https://doi.org/10.1159/000365993openalex-snapshot
Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
inferredcites →https://doi.org/10.1159/000367743openalex-snapshot
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000367751openalex-snapshot
Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil
inferredcites →https://doi.org/10.1159/000367760openalex-snapshot
Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000367765openalex-snapshot
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
inferredcites →https://doi.org/10.1159/000367768openalex-snapshot
Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B
inferredcites →https://doi.org/10.1159/000367775openalex-snapshot
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
inferredcites →https://doi.org/10.1159/000367814openalex-snapshot
Acute Eosinophilic and Neutrophilic Pneumonia following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report
inferredcites →https://doi.org/10.1159/000368141openalex-snapshot
Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update
inferredcites →https://doi.org/10.1159/000368142openalex-snapshot
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
inferredcites →https://doi.org/10.1159/000368143openalex-snapshot
Validation of the Criteria of Transcatheter Arterial Chemoembolization Failure or Refractoriness in Patients with Advanced Hepatocellular Carcinoma Proposed by the LCSGJ
inferredcites →https://doi.org/10.1159/000368146openalex-snapshot
Combination Guidance of Contrast-Enhanced US and Fusion Imaging in Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Contrast-Enhanced US/Fusion Imaging
inferredcites →https://doi.org/10.1159/000368152openalex-snapshot
Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis
inferredcites →https://doi.org/10.1159/000439290openalex-snapshot
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
inferredcites →https://doi.org/10.1159/000448855openalex-snapshot
Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000452846openalex-snapshot
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications
inferredcites →https://doi.org/10.1159/000462153openalex-snapshot
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
inferredcites →https://doi.org/10.1159/000480208openalex-snapshot
Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2
inferredcites →https://doi.org/10.1159/000480256openalex-snapshot
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis
inferredcites →https://doi.org/10.1159/000481242openalex-snapshot
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
inferredcites →https://doi.org/10.1159/000484619openalex-snapshot
Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
inferredcites →https://doi.org/10.1159/000488778openalex-snapshot
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
inferredcites →https://doi.org/10.1159/000492533openalex-snapshot
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000501082openalex-snapshot
B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial
inferredcites →https://doi.org/10.1159/000501501openalex-snapshot
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials
inferredcites →https://doi.org/10.1159/000502744openalex-snapshot
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients
inferredcites →https://doi.org/10.1159/000502905openalex-snapshot
A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE
inferredcites →https://doi.org/10.1159/000503577openalex-snapshot
18F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib
inferredcites →https://doi.org/10.1159/000505189openalex-snapshot
A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
inferredcites →https://doi.org/10.1159/000505190openalex-snapshot
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis
inferredcites →https://doi.org/10.1159/000507370openalex-snapshot
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
inferredcites →https://doi.org/10.1159/000507934openalex-snapshot
A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000508724openalex-snapshot
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1159/000509554openalex-snapshot
Gd-EOB-DTPA-MRI Could Predict WNT/β-Catenin Mutation and Resistance to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1200/jco.19.01307openalex-snapshot
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
inferredcites →https://doi.org/10.1200/jco.20.00808openalex-snapshot
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1200/jco.2018.36.15_suppl.4018openalex-snapshot
Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.
inferredcites →https://doi.org/10.1200/jco.2019.37.15_suppl.4002openalex-snapshot
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.4518openalex-snapshot
A prospective randomized controlled trial of selective transarterial chemoembolization using drug-eluting beads loaded with epirubicin versus selective conventional transarterial chemoembolization using epirubicin-lipiodol for hepatocellular carcinoma: The JIVROSG-1302 PRESIDENT study.
inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.4581openalex-snapshot
A multicenter nonrandomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF cohort trial).
inferredcites →https://doi.org/10.2214/ajr.08.1618openalex-snapshot
Efficacy of Perflubutane Microbubble-Enhanced Ultrasound in the Characterization and Detection of Focal Liver Lesions: Phase 3 Multicenter Clinical Trial
inferredcites →https://doi.org/10.2214/ajr.09.3730openalex-snapshot
Hepatic Hemangioma and Metastasis: Differentiation With Gadoxetate Disodium–Enhanced 3-T MRI
inferredcites →https://doi.org/10.2214/ajr.10.5390openalex-snapshot
Evolution of Hypointense Hepatocellular Nodules Observed Only in the Hepatobiliary Phase of Gadoxetate Disodium–Enhanced MRI
inferredcites →https://doi.org/10.2214/ajr.172.4.10587130openalex-snapshot
Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
inferredcites →https://doi.org/10.3390/cancers11030405openalex-snapshot
Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3390/cancers11070952openalex-snapshot
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
inferredcites →https://doi.org/10.3390/cancers11081084openalex-snapshot
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
inferredcites →https://doi.org/10.3748/wjg.v12.i5.828openalex-snapshot
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan
inferredcites →https://doi.org/10.3892/or.4.3.525openalex-snapshot
Hepatocellular carcinoma with sarcomatous change
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4141631openalex-extracted
Circular RNA hsa_circ_0005218 Promotes the Early Recurrence of Hepatocellular Carcinoma by Targeting the miR-31-5p/CDK1 Pathway
inferred← citeshttps://doi.org/10.2139/ssrn.4834019openalex-extracted
Cost-Effectiveness of the Clinical Management of Hepatocellular Carcinoma in Four Asian-Pacific Countries
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.47995openalex-snapshot
Locoregional Therapies for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/ags3.70010openalex-snapshot
FIB‐3 index as a novel age‐independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy
inferred← citeshttps://doi.org/10.1002/ags3.70186openalex-snapshot
Prognostic Significance of Portal Vein Tumor Thrombus in Pancreatic Ductal Adenocarcinoma Treated With Chemoradiotherapy
inferred← citeshttps://doi.org/10.1002/cai2.70006openalex-snapshot
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021
inferred← citeshttps://doi.org/10.1002/cam4.4850openalex-snapshot
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan
inferred← citeshttps://doi.org/10.1002/cam4.5810openalex-snapshot
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy
inferred← citeshttps://doi.org/10.1002/cam4.5841openalex-snapshot
Correlation and efficacy of TACE combined with lenvatinib plus PD ‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features
inferred← citeshttps://doi.org/10.1002/cam4.6046openalex-snapshot
Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
inferred← citeshttps://doi.org/10.1002/cam4.6416openalex-snapshot
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
inferred← citeshttps://doi.org/10.1002/cam4.6726openalex-snapshot
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach
inferred← citeshttps://doi.org/10.1002/cam4.6836openalex-snapshot
Efficiency and safety of hepatic arterial infusion chemotherapy ( HAIC ) combined with anti‐ PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis
inferred← citeshttps://doi.org/10.1002/cam4.7025openalex-snapshot
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.70367openalex-snapshot
Predictors of Immediate Deterioration of the Child‐Pugh Classification From A to B After Transcatheter Arterial Chemo‐Embolization for Treatment‐Naive Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.7068openalex-snapshot
Laparoscopic liver resection versus radiofrequency ablation for caudate lobe solitary hepatocellular carcinoma: A propensity score matching study
inferred← citeshttps://doi.org/10.1002/cam4.71552openalex-snapshot
Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.71594openalex-snapshot
The Clinical Impact of Cardiovascular Thrombosis on Overall Survival in Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization
inferred← citeshttps://doi.org/10.1002/cam4.71639openalex-snapshot
Prospective Registry and Meta‐Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real‐World Impact
inferred← citeshttps://doi.org/10.1002/cam4.71640openalex-snapshot
Three‐Year Long‐Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice
inferred← citeshttps://doi.org/10.1002/cncr.34559openalex-snapshot
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice
inferred← citeshttps://doi.org/10.1002/cnr2.2042openalex-snapshot
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cnr2.70697openalex-snapshot
Tumor Number and Model for End‐Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate‐Stage Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/hsr2.70655openalex-snapshot
High Plasma Alpha‐Fetoprotein Level Is Associated With Early Postoperative Complications in Patients With Hepatocellular Carcinoma in Southern Vietnam During 2018–2023: A Cross‐Sectional Study
inferred← citeshttps://doi.org/10.1002/jcla.24990openalex-snapshot
Chinese expert consensus statement on the clinical application of AFP / AFP‐L3 %/ DCP using GALAD and GALAD ‐like algorithm in HCC
inferred← citeshttps://doi.org/10.1002/jcla.70114openalex-snapshot
Characterization of PIVKA ‐ II Molecular Forms via Size Exclusion Chromatography and Hydrophobic Interaction Chromatography in HCC Patients
inferred← citeshttps://doi.org/10.1002/jgh3.12753openalex-snapshot
Comparison between using hepatocellular carcinoma ( HCC ) risk scores and the HCC national guideline to identify high‐risk chronic hepatitis B patients for HCC surveillance in Thailand
inferred← citeshttps://doi.org/10.1002/jgh3.12777openalex-snapshot
Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
inferred← citeshttps://doi.org/10.1002/jgh3.12879openalex-snapshot
Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment
inferred← citeshttps://doi.org/10.1002/jgh3.70145openalex-snapshot
Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/jgh3.70226openalex-snapshot
Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer Patients With Concurrent Advanced Malignancies With Expected Poor Prognosis
inferred← citeshttps://doi.org/10.1002/jhbp.1408openalex-snapshot
Questionnaire survey of Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors on the surgical indications for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jhbp.70182openalex-snapshot
Liver Transplantation Versus Resection for Single‐Nodule Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1002/jmri.29052openalex-snapshot
Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/jmri.29404openalex-snapshot
Deep Learning–Based Approach for Identifying and Measuring Focal Liver Lesions on Contrast‐Enhanced MRI
inferred← citeshttps://doi.org/10.1002/jso.27023openalex-snapshot
Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score‐matching cohort study
inferred← citeshttps://doi.org/10.1002/kjm2.12757openalex-snapshot
Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib
inferred← citeshttps://doi.org/10.1002/kjm2.12838openalex-snapshot
Role of reimbursement and Physicians' awareness in the survival of sorafenib‐eligible advanced hepatocellular carcinoma patients
inferred← citeshttps://doi.org/10.1002/lci2.74openalex-snapshot
Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/mco2.70805openalex-snapshot
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First‐line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non‐comparative, Randomized Phase 2 Trial
inferred← citeshttps://doi.org/10.1002/poh2.85openalex-snapshot
Tumor budding is a meaningful prognostic marker in patients with hepatocellular carcinoma after curative hepatectomy
inferred← citeshttps://doi.org/10.1002/ueg2.12554openalex-snapshot
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives
inferred← citeshttps://doi.org/10.1007/978-3-030-51192-0_84-1openalex-snapshot
Combination Therapies for Primary Liver Cancer
inferred← citeshttps://doi.org/10.1007/s00228-024-03718-1openalex-snapshot
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis
inferred← citeshttps://doi.org/10.1007/s00261-022-03681-4openalex-snapshot
Positive predictive value of LI-RADS US-3 observations: multivariable analysis of clinical and imaging features
inferred← citeshttps://doi.org/10.1007/s00261-023-04024-7openalex-snapshot
Subcentimeter hepatocellular carcinoma (HCC) on gadoxetic-acid-enhanced MRI: less frequent typical imaging features compared to 1–2 cm HCC but better prognosis after surgical resection
inferred← citeshttps://doi.org/10.1007/s00261-023-04043-4openalex-snapshot
Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies
inferred← citeshttps://doi.org/10.1007/s00261-025-04825-yopenalex-snapshot
Relationship between contrast-enhanced ultrasound combined with ultrasound resolution microscopy imaging and histological features of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00261-025-05285-0openalex-snapshot
Artificial intelligence-driven CT radiomics model predicts prognosis in TACE-refractory hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00261-026-05810-9openalex-snapshot
Photon-counting detector CT for follow-up after TACE in hepatocellular carcinoma: effects of reconstruction kernel and sharpness
inferred← citeshttps://doi.org/10.1007/s00262-023-03511-6openalex-snapshot
Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study
inferred← citeshttps://doi.org/10.1007/s00262-025-04122-zopenalex-snapshot
TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
inferred← citeshttps://doi.org/10.1007/s00262-026-04476-yopenalex-snapshot
Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00270-024-03724-xopenalex-snapshot
Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis
inferred← citeshttps://doi.org/10.1007/s00270-024-03730-zopenalex-snapshot
Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness
inferred← citeshttps://doi.org/10.1007/s00330-022-09282-5openalex-snapshot
An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid–enhanced MRI
inferred← citeshttps://doi.org/10.1007/s00330-023-09928-yopenalex-snapshot
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management
inferred← citeshttps://doi.org/10.1007/s00330-023-09961-xopenalex-snapshot
Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization
inferred← citeshttps://doi.org/10.1007/s00330-023-10006-6openalex-snapshot
Feeding artery: a valuable feature for differentiation of regenerative nodule, dysplastic nodules and small hepatocellular carcinoma in CEUS LI-RADS
inferred← citeshttps://doi.org/10.1007/s00330-023-10214-0openalex-snapshot
Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid–enhanced MRI
inferred← citeshttps://doi.org/10.1007/s00330-024-11295-1openalex-snapshot
MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort study
inferred← citeshttps://doi.org/10.1007/s00330-026-12696-0openalex-snapshot
LI-RADS v2018 versus KLCA-NCC v2022: comparison of probability-based HCC categories
inferred← citeshttps://doi.org/10.1007/s00423-023-03057-2openalex-snapshot
Prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO)
inferred← citeshttps://doi.org/10.1007/s00428-023-03568-9openalex-snapshot
MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00428-024-03939-wopenalex-snapshot
Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00432-023-05526-zopenalex-snapshot
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00432-025-06233-7openalex-snapshot
Optimal sequencing of locoregional and systemic therapies for intermediate and advanced hepatocellular carcinoma: a network meta-analysis
inferred← citeshttps://doi.org/10.1007/s00464-022-09677-xopenalex-snapshot
Influence of Child–Pugh B7 and B8/9 cirrhosis on laparoscopic liver resection for hepatocellular carcinoma: a retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00464-024-10937-1openalex-snapshot
Outcomes after laparoscopic or open liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a propensity score-matching study
inferred← citeshttps://doi.org/10.1007/s00535-023-01962-3openalex-snapshot
Factors for the recurrence of hepatocellular carcinoma after hepatic resection
inferred← citeshttps://doi.org/10.1007/s00535-023-01976-xopenalex-snapshot
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis
inferred← citeshttps://doi.org/10.1007/s00535-023-01985-wopenalex-snapshot
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00535-023-02018-2openalex-snapshot
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study
inferred← citeshttps://doi.org/10.1007/s00535-025-02233-zopenalex-snapshot
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study
inferred← citeshttps://doi.org/10.1007/s00535-025-02308-xopenalex-snapshot
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00535-026-02345-0openalex-snapshot
Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan
inferred← citeshttps://doi.org/10.1007/s00535-026-02406-4openalex-snapshot
Lenvatinib plus hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leucovorin versus lenvatinib alone for advanced hepatocellular carcinoma: a multicenter retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00595-023-02710-zopenalex-snapshot
Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria
inferred← citeshttps://doi.org/10.1007/s00595-024-02914-xopenalex-snapshot
Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy
inferred← citeshttps://doi.org/10.1007/s00595-025-03217-5openalex-snapshot
Prognostic significance of Albumin–Bilirubin score changes in patients treated with systemic therapy for recurrent hepatocellular carcinoma after liver resection
inferred← citeshttps://doi.org/10.1007/s10147-022-02159-zopenalex-snapshot
Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors
inferred← citeshttps://doi.org/10.1007/s10147-022-02166-0openalex-snapshot
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s10147-025-02740-2openalex-snapshot
Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study
inferred← citeshttps://doi.org/10.1007/s10147-026-03141-9openalex-snapshot
Clinical impact of salvage hepatectomy for local recurrence of hepatocellular carcinoma after radiofrequency ablation or selective transarterial chemoembolization
inferred← citeshttps://doi.org/10.1007/s10278-024-01003-2openalex-snapshot
Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
inferred← citeshttps://doi.org/10.1007/s10278-025-01817-8openalex-snapshot
Pathobiological Dictionary Defining Pathomics and Texture Features: Addressing Understandable AI Issues in Personalized Liver Cancer; Dictionary Version LCP1.0
inferred← citeshttps://doi.org/10.1007/s10278-026-02080-1openalex-snapshot
Automatic Phase and Sequence Identification in Gd-EOB-DTPA–Enhanced Liver MRI Using Deep Convolutional and Sequential Learning
inferred← citeshttps://doi.org/10.1007/s10396-022-01273-9openalex-snapshot
Understanding the differences between Japanese and U.S. guidelines on clinical practice for contrast-enhanced ultrasound of the liver
inferred← citeshttps://doi.org/10.1007/s10396-023-01390-zopenalex-snapshot
Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound
inferred← citeshttps://doi.org/10.1007/s10396-025-01598-1openalex-snapshot
Differentiation of focal liver lesions in contrast-enhanced ultrasound using a heuristic-guided hybrid machine-learning framework
inferred← citeshttps://doi.org/10.1007/s10585-022-10188-1openalex-snapshot
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
inferred← citeshttps://doi.org/10.1007/s10620-025-08884-5openalex-snapshot
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s10637-022-01303-wopenalex-snapshot
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
inferred← citeshttps://doi.org/10.1007/s10637-023-01349-4openalex-snapshot
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group
inferred← citeshttps://doi.org/10.1007/s10637-024-01441-3openalex-snapshot
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)
inferred← citeshttps://doi.org/10.1007/s11427-024-2722-2openalex-snapshot
Epidemiology of liver diseases: global disease burden and forecasted research trends
inferred← citeshttps://doi.org/10.1007/s11547-025-02034-7openalex-snapshot
Improving diagnostic accuracy in cirrhotic patients: a comprehensive multicenter analysis of contrast-enhanced ultrasound-guided biopsy in a large cohort of 2056 patients
inferred← citeshttps://doi.org/10.1007/s11605-022-05421-xopenalex-snapshot
Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study
inferred← citeshttps://doi.org/10.1007/s11605-023-05802-wopenalex-snapshot
Albumin-Bilirubin Score at Post-Hepatectomy Hepatocellular Carcinoma Recurrence: Impact on Survival and Association with Post-Hepatectomy Liver Failure
inferred← citeshttps://doi.org/10.1007/s11655-024-4111-zopenalex-snapshot
Cinobufacini Inhibits Survival and Metastasis of Hepatocellular Carcinoma via c-Met Signaling Pathway
inferred← citeshttps://doi.org/10.1007/s11901-025-00686-7openalex-snapshot
The Role of AFP-L3 and DCP Biomarkers in the Diagnosis and Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s12010-023-04443-8openalex-snapshot
Expression Patterns of HOX Gene Family Defines Tumor Microenvironment and Immunotherapy in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s12029-023-00999-0openalex-snapshot
Efficacy of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma: a Meta-analysis
inferred← citeshttps://doi.org/10.1007/s12029-024-01036-4openalex-snapshot
Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study
inferred← citeshttps://doi.org/10.1007/s12029-026-01554-3openalex-snapshot
Novel Strategies for the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Review
inferred← citeshttps://doi.org/10.1007/s12033-024-01233-3openalex-snapshot
Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s12072-023-10599-6openalex-snapshot
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
inferred← citeshttps://doi.org/10.1007/s12072-024-10732-zopenalex-snapshot
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
inferred← citeshttps://doi.org/10.1007/s12072-024-10762-7openalex-snapshot
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
inferred← citeshttps://doi.org/10.1007/s12072-025-10879-3openalex-snapshot
Stage-specific impact of portal hypertension on outcomes after liver resection in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s12072-026-11110-7openalex-snapshot
Identifying a biologically high-risk subgroup of anatomically resectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s12328-022-01605-9openalex-snapshot
Two cases of rapid progression of esophageal varices after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s12328-022-01644-2openalex-snapshot
A case of conversion hepatectomy for huge hepatocellular carcinoma with adrenal metastasis and vascular invasion after atezolizumab–bevacizumab treatment
inferred← citeshttps://doi.org/10.1007/s12328-022-01669-7openalex-snapshot
A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases
inferred← citeshttps://doi.org/10.1007/s12328-023-01775-0openalex-snapshot
Three cases of immune-related hypopituitarism after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s12672-024-01026-9openalex-snapshot
Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s12672-025-04132-4openalex-snapshot
Hepatic arterial infusion chemotherapy via arterial infusion port combined with Atezolizumab and Bevacizumab for conversion therapy of advanced hepatocellular carcinoma: a case report
inferred← citeshttps://doi.org/10.1007/s13304-026-02773-wopenalex-snapshot
Additive value of oncological resectability criteria for predicting post-hepatectomy liver failure in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s13691-023-00618-6openalex-snapshot
Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence
inferred← citeshttps://doi.org/10.1016/b978-0-12-823524-9.00010-1openalex-snapshot
Oncologic liver transplantation: Transplant oncology
inferred← citeshttps://doi.org/10.1016/b978-0-443-21938-2.00020-5openalex-snapshot
Hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.aca.2024.343533openalex-snapshot
A new platform of electrowetting-on-dielectric digital microfluidics for rapid detection of early-stage Hepatocellular Carcinoma(HCC) specific biomarker
inferred← citeshttps://doi.org/10.1016/j.acra.2024.09.066openalex-snapshot
Nomogram to Predict Tumor Remnant of Small Hepatocellular Carcinoma after Microwave Ablation
inferred← citeshttps://doi.org/10.1016/j.acra.2025.02.012openalex-snapshot
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCC
inferred← citeshttps://doi.org/10.1016/j.acra.2026.09.028openalex-snapshot
Trends and Hotspots of Microwave Ablation in the Treatment of Hepatocellular Carcinoma: A Bibliometric Analysis From 2010 to 2025
inferred← citeshttps://doi.org/10.1016/j.adro.2024.101441openalex-snapshot
Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2025.116716openalex-snapshot
Development and validation of machine learning-based model for predicting early recurrence for patients with HBV-associated hepatocellular carcinoma after curative hepatectomy
inferred← citeshttps://doi.org/10.1016/j.aohep.2025.101943openalex-snapshot
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011–2019
inferred← citeshttps://doi.org/10.1016/j.apjon.2025.100804openalex-snapshot
Applying quality indicators and multidisciplinary team care to improve long-term survival in early-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.asjsur.2025.09.181openalex-snapshot
Impact of laparoscopic approach on volumetric and functional liver recovery in advanced hepatectomy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.189016openalex-snapshot
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.07.047openalex-snapshot
HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression
inferred← citeshttps://doi.org/10.1016/j.bj.2024.100815openalex-snapshot
Hepatocellular carcinoma systemic treatment update: From early to advanced stage
inferred← citeshttps://doi.org/10.1016/j.cgh.2023.01.039openalex-snapshot
Breakthroughs in Hepatocellular Carcinoma Therapies
inferred← citeshttps://doi.org/10.1016/j.cld.2024.08.003openalex-snapshot
Embolic and Ablative Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2024.08.008openalex-snapshot
Hepatic Resection for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2024.08.010openalex-snapshot
Systemic Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.clinimag.2025.110438openalex-snapshot
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.107694openalex-snapshot
Multi-cohort validation study of a four-gene signature for risk stratification and treatment response prediction in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.crad.2023.09.015openalex-snapshot
Comparison of contrast-enhanced ultrasonography and MRI results obtained by expert and novice radiologists indicating short-term response after transarterial chemoembolisation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.cson.2026.100127openalex-snapshot
Locoregional combined systemic therapies for unresectable hepatocellular carcinoma in the era of immunotherapy: a narrative review
inferred← citeshttps://doi.org/10.1016/j.ctro.2023.100591openalex-snapshot
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study
inferred← citeshttps://doi.org/10.1016/j.ctrv.2022.102501openalex-snapshot
Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence
inferred← citeshttps://doi.org/10.1016/j.ctrv.2023.102526openalex-snapshot
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
inferred← citeshttps://doi.org/10.1016/j.diii.2022.10.013openalex-snapshot
Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.11.024openalex-snapshot
Immunotherapy in older patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejrad.2023.110895openalex-snapshot
Preoperative MRI-based multiparametric model for survival prediction in hepatocellular carcinoma patients with portal vein tumor thrombus following hepatectomy
inferred← citeshttps://doi.org/10.1016/j.ejrad.2025.112057openalex-snapshot
A nationwide investigation on imaging follow-up after Locoregional therapy for hepatocellular carcinoma in China: Current practices and challenges
inferred← citeshttps://doi.org/10.1016/j.ejro.2024.100551openalex-snapshot
Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
inferred← citeshttps://doi.org/10.1016/j.hbpd.2022.05.003openalex-snapshot
Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis
inferred← citeshttps://doi.org/10.1016/j.hbpd.2022.12.001openalex-snapshot
State of the art and perspectives in liver transplantation
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e14816openalex-snapshot
RETRACTED: Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e27355openalex-snapshot
Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not
inferred← citeshttps://doi.org/10.1016/j.heliyon.2026.e45555openalex-snapshot
Genomic alterations in hepatocellular carcinoma patients undergoing liver transplantation predict recurrence and prognosis
inferred← citeshttps://doi.org/10.1016/j.hpb.2022.11.008openalex-snapshot
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.hpb.2023.03.004openalex-snapshot
Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis
inferred← citeshttps://doi.org/10.1016/j.hpb.2023.09.002openalex-snapshot
Short- and long-term outcomes of laparoscopic liver resection for non-alcoholic fatty liver disease-associated hepatocellular carcinoma: a retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.hpb.2023.09.015openalex-snapshot
The management and outcomes of hepatocellular carcinoma in sub-Saharan Africa: a systematic review
inferred← citeshttps://doi.org/10.1016/j.hpr.2022.300597openalex-snapshot
Are hepatocellular neoplasms with a Cytokeratin 7-positive pseudoglandular pattern destined for malignant transformation? A comparison of two cases
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2025.12.019openalex-snapshot
Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.iliver.2022.11.003openalex-snapshot
Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study
inferred← citeshttps://doi.org/10.1016/j.iliver.2025.100187openalex-snapshot
Debates and progress in the management of intermediate-stage (BCLC stage B) hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.isci.2024.108797openalex-snapshot
A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jceh.2024.101474openalex-snapshot
Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies
inferred← citeshttps://doi.org/10.1016/j.jceh.2024.102406openalex-snapshot
Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.01.010openalex-snapshot
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101263openalex-snapshot
Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies
inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101269openalex-snapshot
Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101420openalex-snapshot
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101509openalex-snapshot
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhepr.2025.101565openalex-snapshot
Anatomical resection is associated with reduced early recurrences in HCC: A machine learning analysis
inferred← citeshttps://doi.org/10.1016/j.jvir.2026.108861openalex-snapshot
Radiologic Morphologies Predict Tumor Response and Patient Survival Following Chemoembolization for Single Large (>5 to ≤10 cm) Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.lfs.2024.122540openalex-snapshot
Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
inferred← citeshttps://doi.org/10.1016/j.livres.2024.03.001openalex-snapshot
Physical activity and exercise in liver cancer
inferred← citeshttps://doi.org/10.1016/j.pathol.2025.12.006openalex-snapshot
Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers
inferred← citeshttps://doi.org/10.1016/j.prmcm.2025.100581openalex-snapshot
The knowledge mapping of traditional Chinese medicine for hepatocellular carcinoma: A bibliometric study
inferred← citeshttps://doi.org/10.1016/j.semcancer.2023.04.010openalex-snapshot
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
inferred← citeshttps://doi.org/10.1016/j.soc.2023.06.005openalex-snapshot
Hepatocellular Carcinoma Surveillance
inferred← citeshttps://doi.org/10.1016/j.surg.2023.06.022openalex-snapshot
Long-term outcomes and salvageability in patients undergoing liver resection for intermediate- and advanced-stage hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.suronc.2024.102114openalex-snapshot
Perioperative outcomes after hepatectomy for hepatocellular carcinoma among patients with cirrhosis, fatty liver disease, and clinically normal livers
inferred← citeshttps://doi.org/10.1016/j.trecan.2025.02.006openalex-snapshot
Myeloid cell path to malignancy: insights into liver cancer
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2023.07.001openalex-snapshot
Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2023.07.008openalex-snapshot
Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2024.08.020openalex-snapshot
A Nomogram Based on Features of Ultrasonography and Contrast-Enhanced CT to Predict Vessels Encapsulating Tumor Clusters Pattern of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2026.06.007openalex-snapshot
Change in Two-Dimensional Shear Wave Elastography: A New Predictor of Hepatitis B-Related HCC Progression After Ablation
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)01200-4openalex-snapshot
Hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/s0140-6736(24)02575-3openalex-snapshot
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
inferred← citeshttps://doi.org/10.1016/s1470-2045(21)00604-5openalex-snapshot
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
inferred← citeshttps://doi.org/10.1016/s1470-2045(23)00186-9openalex-snapshot
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
inferred← citeshttps://doi.org/10.1016/s1470-2045(26)00278-0openalex-snapshot
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
inferred← citeshttps://doi.org/10.1016/s2468-1253(22)00042-5openalex-snapshot
Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions
inferred← citeshttps://doi.org/10.1021/acsptsci.6c00291openalex-snapshot
Safety and Efficacy of Adebrelimab plus Apatinib Combined with Hepatic Artery Infusion Chemotherapy for the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study
inferred← citeshttps://doi.org/10.1038/s41392-025-02498-zopenalex-snapshot
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study
inferred← citeshttps://doi.org/10.1038/s41467-023-43670-9openalex-snapshot
SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41467-024-52700-zopenalex-snapshot
Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial
inferred← citeshttps://doi.org/10.1038/s41571-023-00816-4openalex-snapshot
Biomarkers for immunotherapy of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41571-024-00868-0openalex-snapshot
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41575-023-00818-8openalex-snapshot
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
inferred← citeshttps://doi.org/10.1038/s41598-023-39954-1openalex-snapshot
Using AI and Gd-EOB-DTPA-enhanced MR imaging to assess liver function, comparing the MELIF score with the ALBI score
showing the first 200 of 672 · page through all 672
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.